previous compound ID: 2617 next compound
InChIKey: XOEVKNFZUQEERE-UHFFFAOYSA-N
SMILES: CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "B Kus" "J Goepp" "JW Hanrahan" "D Rotin" "R Robert" "DY Thomas" "SD Macknight" "GW Carlile" "E Matthes"

chemical graph of compound 2617





CID is 441345
synonyms found at PubChem are:
Flavoxate hydrochloride, 3717-88-2, Flavoxate HCL, DW-61, Bladderon, Peflate, Spasmal, Flavoxate (hydrochloride), DW 61 (flavoxate), UNII-9C05J6089W, Flavoxate hydrochloride, NSC-114649, Rec 7/0040, CHEBI:5089, Rec-7-0040, 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride, 9C05J6089W, Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride, 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride, C24H26ClNO4, DSSTox_CID_27764, DSSTox_RID_82541, DSSTox_GSID_47784, Verrispasmin amp., 3-Methyl-4-oxo-2-phenyl-4H-benzopyran-8-carboxylic acid 2-piperidinyl ethyl ester, 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride, NSC114649, NCGC00016636-01, CAS-3717-88-2, SR-01000872667, 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochloride, Prestwick_884, Flavoxate hydrochloride [USAN:USP:JAN], AC1L9B0J, Rec-7-0040 HCl, MLS002154247, SCHEMBL124540, CHEMBL1200875, DTXSID1047784, CTK8B3835, HY-B0549A, KS-00000XSH, AOB5638, MolPort-003-986-802, 1-Piperidinoethanol, hydrochloride, HMS1568B06, BCP13298, Tox21_110537, ANW-43270, MFCD00072099, s4027, AKOS025310107, Flavoxate hydrochloride (JP17/USAN), Tox21_110537_1, AC-1093, API0002707, CCG-220242, CS-2652, RL03419, DW-61;Rec-7-0040;DW61, NCGC00016636-05, AN-15251, AS-12321, BC222362, CC-28434, SMR000499576, ACM1189678430, AB0011722, TL8002737, TR-015131, F0717, FT-0658191, FT-0668549, D00718, J10335, 27814-EP2269989A1, 27814-EP2298767A1, 27814-EP2298772A1, 27814-EP2308839A1, 27814-EP2314587A1, Flavoxate hydrochloride, >=98% (HPLC), solid, C-34896, J-521367, SR-01000872667-1, WLN: T66 BO EVJ CR& D1 JVO2- AT6NTJ &GH, 4H-1-Benzopyran-8-carboxylic acid, 2-piperidinoethyl ester, hydrochloride, Flavoxate hydrochloride, European Pharmacopoeia (EP) Reference Standard, Flavoxate hydrochloride, United States Pharmacopeia (USP) Reference Standard, 1-(2-{[(3-methyl-4-oxo-2-phenyl-4H-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium chloride, 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate hydrochloride, 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate hydrochloride, 2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride, 4H-1-Benzopyran-8-carboxylic acid, 2-(1-piperidinyl)ethyl ester, hydrochloride, AKOS015896479, A823554, I06-1881, hydron; 2-piperidin-1-ylethyl 3-methyl-4-oxidanylidene-2-phenyl-chromene-8-carboxylate; chloride, hydron; 3-methyl-4-oxo-2-phenyl-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester; chloride